Bioabsorbable Stents Market worth 2.4 Billion USD by 2021 - PowerPoint PPT Presentation


PPT – Bioabsorbable Stents Market worth 2.4 Billion USD by 2021 PowerPoint presentation | free to download - id: 871be3-OWI4M


The Adobe Flash plugin is needed to view this content

Get the plugin now

View by Category
About This Presentation

Bioabsorbable Stents Market worth 2.4 Billion USD by 2021


Bioabsorbable Stents Market by Material (Polymer, Metal), Procedure (Invasive), Absorption Rate (Slow, Fast), Drugs (Limus drugs, Paclitaxel), Application (CAD, PAD), End User (Hospital, Cardiac Centers) - Global Forecast to 2021 – PowerPoint PPT presentation

Number of Views:11


Write a Comment
User Comments (0)
Transcript and Presenter's Notes

Title: Bioabsorbable Stents Market worth 2.4 Billion USD by 2021

MarketsandMarkets Presents
Bioabsorbable Stents Market - Effect of Presence
of Substitutes and High Risk of Complications on
Growth Opportunity
The "Bioabsorbable Stents Market Material
(Polymer, Metal), Procedure (Invasive),
Absorption Rate (Slow, Fast), Drugs (Limus drugs,
Paclitaxel), Application (CAD, PAD), End User
(Hospital, Cardiac Centers) - Forecast to 2021",
report provides a detailed overview of the major
drivers, restraints, challenges, opportunities,
current market trends, and strategies impacting
the Bioabsorbable Stents market along with the
estimates and forecasts of the revenue and market
share analysis. Browse 90 market data tables 42
figures 156 pages And in-depth TOC on
Bioabsorbable Stents Market Download The PDF
Brochure_at_ http//
load.asp?id40983380 The global bioabsorbable
stents market is expected to reach USD 2.4
Billion by 2021 from USD 0.4 Billion by 2016, at
a CAGR of 42.5 during the forecast period.
The major driving factors are the increasing
focus of the companies on clinical trials of
bioabsorbable stents, increasing aging
population, technological advancements, and
patients preference for minimally invasive
therapies. However, factors such as the high
prices of these stents may hamper the growth of
the market. Request Sample_at_ http//www.marketsan The
bioabsorbable stents market is segmented on the
basis of Material, absorption rate, application,
end user, and region. Based on material, the
market is segmented into polymer stents, and
metallic stents.
The polymer stents segment is expected to grow
at the highest CAGR due to the various facts such
as polymer-based bioabsorbable stents comprise
PLLA polymers that are naturally biodegradable.
These stents have a polymer coating of
poly-D,L-lactide, which enables the controlled
release of various drugs. By absorption rate,
the market is sub-segmented into fast and slow
bioabsorbable stents. In 2016, slow absorbable
stents is expected to account for the largest
share of the absorption rate. The growth in this
segment is attributed to slow rate of absorption
enables the longer duration of drug release
within the arteries. This ensures efficient
Geographically, the bioabsorbable stents market
is dominated by Europe, followed by North
America. North American market is expected to
grow at the highest CAGR of 46.1 during the
forecast period. This growth can be attributed to
due to the increase in aging population,
unhealthy lifestyle habits, and the strong
healthcare infrastructure in this market. The
bioabsorbable stent market has fewer numbers of
players. Prominent players in the market include
Abbott (U.S.), Elixir Medical Corporation (U.S.),
Kyoto Medical Co. LTD. (Japan), Reva Medical Inc.
(U.S.), Arterial Remodeling Technologies
(France), Tepha Inc. (U.S.), Meril Life Sciences
Pvt. Ltd. (India) among others.
About MarketsandMarkets MarketsandMarkets
provides quantified B2B research on 30,000 high
growth niche opportunities/threats which will
impact 70 to 80 of worldwide companies
revenues. Currently servicing 5000 customers
worldwide including 80 of global Fortune 1000
companies as clients. Almost 75,000 top officers
across eight industries worldwide approach
MarketsandMarkets for their painpoints around
revenues decisions.   Our 850 fulltime analyst
and SMEs at MarketsandMarkets are tracking
global high growth markets following the "Growth
Engagement Model GEM". The GEM aims at
proactive collaboration with the clients to
identify new opportunities, identify most
important customers, write "Attack, avoid and
defend" strategies, identify sources of
incremental revenues for both the company and its
competitors. MarketsandMarkets now coming up
with 1,500 MicroQuadrants (Positioning top
players across leaders, emerging companies,
innovators, strategic players) annually in high
growth emerging segments. MarketsandMarkets is
determined to benefit more than 10,000 companies
this year for their revenue planning and help
them take their innovations/disruptions early to
the market by providing them research ahead of
the curve.   MarketsandMarketss flagship
competitive intelligence and market research
platform, "RT" connects over 200,000 markets and
entire value chains for deeper understanding of
the unmet insights along with market sizing and
forecasts of niche markets.   
Contact Us
Mr. Rohan MarketsandMarkets 701 Pike Street
Suite 2175, Seattle, WA 98101, United States
Tel 1-888-600-6441 Email sales_at_marketsandmarket MarketsandMarkets Bloghttp//www.marketsan
dmarkets.comhttp// htt
(No Transcript)